West Pharmaceutical Services Stock Today
| WST Stock | USD 220.15 0.92 0.42% |
PerformanceVery Weak
| Odds Of DistressVery Low
|
West Pharmaceutical is selling for under 220.15 as of the 26th of February 2025; that is 0.42 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 218.8. West Pharmaceutical has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on December 9, 2024, Representative Jared Moskowitz of US Congress acquired under $15k worth of West Pharmaceutical's common stock.
Business Domain Health Care Equipment & Services | IPO Date 13th of January 1978 | Category Healthcare | Classification Health Care |
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. West Pharmaceutical Services, Inc. The company has 72.3 M outstanding shares of which 1.34 M shares are at this time shorted by investors with about 3.15 days to cover. More on West Pharmaceutical Services
Moving together with West Stock
Moving against West Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
West Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Eric Green | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Wistil S.A. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Rubber and Plastic Products, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsWest Pharmaceutical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand West Pharmaceutical's financial leverage. It provides some insight into what part of West Pharmaceutical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
West Pharmaceutical Services (WST) is traded on New York Stock Exchange in USA. It is located in 530 Herman O. West Drive, Exton, PA, United States, 19341-1147 and employs 10,600 people. West Pharmaceutical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 15.92 B. West Pharmaceutical runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 72.3 M outstanding shares of which 1.34 M shares are at this time shorted by investors with about 3.15 days to cover.
West Pharmaceutical Services has about 894.3 M in cash with 653.4 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.85.
Check West Pharmaceutical Probability Of Bankruptcy
Ownership AllocationWest Pharmaceutical Services retains a total of 72.3 Million outstanding shares. The majority of West Pharmaceutical outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in West Pharmaceutical to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in West Pharmaceutical Services. Please pay attention to any change in the institutional holdings of West Pharmaceutical as this could imply that something significant has changed or is about to change at the company. Please note that on December 9, 2024, Representative Jared Moskowitz of US Congress acquired under $15k worth of West Pharmaceutical's common stock.
Check West Ownership Details
West Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Fmr Inc | 2024-12-31 | 1.1 M | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1 M | |
| Norges Bank | 2024-12-31 | 887.2 K | |
| Findlay Park Partners Llp | 2024-12-31 | 834.7 K | |
| Ubs Asset Mgmt Americas Inc | 2024-12-31 | 790.7 K | |
| Northern Trust Corp | 2024-12-31 | 768.8 K | |
| Amvescap Plc. | 2024-12-31 | 755.2 K | |
| T. Rowe Price Investment Management,inc. | 2024-12-31 | 733.3 K | |
| Van Eck Associates Corporation | 2024-12-31 | 689.5 K | |
| Vanguard Group Inc | 2024-12-31 | 9 M | |
| Blackrock Inc | 2024-12-31 | 7.5 M |
West Pharmaceutical Historical Income Statement
West Stock Against Markets
West Pharmaceutical Corporate Directors
| Mark Buthman | Independent Director | Profile | |
| Deborah Tanner | Independent Director | Profile | |
| William Feehery | Independent Director | Profile | |
| Robert Friel | Independent Director | Profile |
Already Invested in West Pharmaceutical Services?
The danger of trading West Pharmaceutical Services is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of West Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than West Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile West Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.